Renalytix annual operating margin
2021
2022
2023
2024
Renalytix's operating margin was −1,293.49% for fiscal 2024.
View full Renalytix company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-06-30 | −1,293.49% | +40927.51 pp |
| 2023 | 2023-06-30 | −42,221.00% | −40430.33 pp |
| 2022 | 2022-06-30 | −1,790.67% | +349.90 pp |
| 2021 | 2021-06-30 | −2,140.58% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2024-09-30 | −784.10% | +1152.50 pp |
| Q4 2024 | 2024-06-30 | −942.83% | +565.04 pp |
| Q3 2024 | 2024-03-31 | −1,224.86% | −415.46 pp |
| Q2 2024 | 2023-12-31 | −1,218.76% | −9.06 pp |
| Q1 2024 | 2023-09-30 | −1,936.60% | — |
| Q3 2023 | 2023-03-31 | −1,507.87% | — |
| Q2 2023 | 2022-12-31 | −809.40% | — |
| Q1 2023 | 2022-09-30 | −1,209.70% | — |
Across the available reported history, Renalytix's operating margin increased from −42,221.00% to −1,293.49%, a change of +40927.51 percentage points. The latest reported quarter, Q1 2025, shows −784.10%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Renalytix filings at SEC.gov ↗